BIIB
FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials
Thursday, July 8, 2021 1 min read
Key Takeaway: FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials
Full Press Release Details
FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials.